Product Monograph - Teva-Ectosone (Teva Canada, 0.1 %)
ADVERSE REACTIONS
With use of topical corticosteroids, local reactions have been reported, namely, burning sensation, itching, irritation, dryness, hypertrichosis, acneiform eruptions, and hypopigmentation. Striae, secondary infection, atrophy, miliaria, folliculitis, and pyodermas also occur but more frequently with use of occlusive dressings. Contact sensitivity to a particular dressing material or adhesive may occur occasionally.
DOSAGE
Shake well before using. Apply a small amount to the affected skin 2 or 3 times daily or as prescribed by the physician. Refractory lesions of psoriasis and other deep-seated dermatoses such as lichen simplex chronicus, hypertrophic lichen planus, atopic dermatitis, chronic eczematous and lichenified hand eruptions, and recalcitrant pustular eruptions on the palms and soles will respond better to topical corticosteroids when used with the hydration technique of occlusive dressing as described in the TEVA-ECTOSONE Prescribing Information.
SUPPLIED: Each g contains: 1.22 mg betamethasone valerate USP, equivalent to 1 mg of betamethasone in a base of carboxypolymethylene, isopropyl alcohol and water. Plastic squeeze bottles of 30 and 75 mL. Store at temperature between 15-30oC. Protect from freezing.